7 Growth Stocks That Are Trading at a Bargain Price

April 4, 2023

in Stocks

Reading Time: 8 mins read

Organon & Co. (OGN)

An image of three yellow arrows on a red background.

Source: smshoot/ShutterStock.com

There are times when low-priced growth stocks are not bargains. And at first glance, that may seem to be the case with Organon & Co. (NYSE:OGN). The healthcare company’s stock is currently trading at around 6.4x earnings and earnings are expected to decline in the next year.

However, the consensus price target of analysts suggests the stock could have an upside of over 45%. And the stock received a bullish upgrade from Raymond James in March. One catalyst is coming from Organon’s biosimilar division which is launching a biosimilar drug that will compete with Humira from AbbVie (NYSE:ABBV).

The stock may also get a boost from its Women’s Health division. Merck & Co. (NYSE:MRK) spinoff is launching its “Her Plan is Her Power” initiative to reduce unplanned pregnancies. And Bloomberg recently reported that the company is seeing an increase in demand for birth control in states where abortion is restricted.